Schedule 13D ownership disclosure

JASPER THERAPEUTICS INC

Voting Common Stock, par value $0.0001 per share · CUSIP: 471871202

Event date: 2026-02-18

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • The Carlyle Group Inc.Reported CIK 0001527166

    Shares: 1,088,310.00 · Class: 3.8%

  • Carlyle Holdings I GP Inc.Reported CIK 0001548626

    Shares: 1,088,310.00 · Class: 3.8%

  • Carlyle Holdings I GP Sub L.L.C.Reported CIK 0001548627

    Shares: 1,088,310.00 · Class: 3.8%

  • Carlyle Holdings I L.P.Reported CIK 0001548628

    Shares: 1,088,310.00 · Class: 3.8%

  • CG Subsidiary Holdings L.L.C.Reported CIK 0001790577

    Shares: 1,088,310.00 · Class: 3.8%

  • TC Group, L.L.C.Reported CIK 0000933790

    Shares: 1,088,310.00 · Class: 3.8%

  • Carlyle Investment Management L.L.C.Reported CIK 0001354120

    Shares: 1,088,310.00 · Class: 3.8%

  • Carlyle Genesis UK LLCReported CIK 0001941860

    Shares: 1,088,310.00 · Class: 3.8%

  • Abingworth LLPReported CIK 0001397144

    Shares: 1,088,310.00 · Class: 3.8%

  • Abingworth Bioventures VII LPReported CIK 0001688313

    Shares: 1,088,310.00 · Class: 3.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-26-007366
Form type
SCHEDULE 13D/A
Filer
Carlyle Group Inc.
CIK
CIK 1527166
Filed
Feb 18, 2026
Reporting period
Feb 18, 2026
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub